收费全文 | 3496篇 |
免费 | 259篇 |
国内免费 | 13篇 |
耳鼻咽喉 | 38篇 |
儿科学 | 88篇 |
妇产科学 | 78篇 |
基础医学 | 485篇 |
口腔科学 | 56篇 |
临床医学 | 359篇 |
内科学 | 733篇 |
皮肤病学 | 80篇 |
神经病学 | 393篇 |
特种医学 | 82篇 |
外科学 | 394篇 |
综合类 | 19篇 |
预防医学 | 420篇 |
眼科学 | 65篇 |
药学 | 229篇 |
中国医学 | 16篇 |
肿瘤学 | 233篇 |
2024年 | 6篇 |
2023年 | 66篇 |
2022年 | 105篇 |
2021年 | 240篇 |
2020年 | 147篇 |
2019年 | 155篇 |
2018年 | 186篇 |
2017年 | 110篇 |
2016年 | 114篇 |
2015年 | 106篇 |
2014年 | 145篇 |
2013年 | 180篇 |
2012年 | 254篇 |
2011年 | 269篇 |
2010年 | 144篇 |
2009年 | 127篇 |
2008年 | 178篇 |
2007年 | 175篇 |
2006年 | 154篇 |
2005年 | 155篇 |
2004年 | 139篇 |
2003年 | 102篇 |
2002年 | 80篇 |
2001年 | 27篇 |
2000年 | 46篇 |
1999年 | 39篇 |
1998年 | 13篇 |
1997年 | 17篇 |
1996年 | 16篇 |
1995年 | 19篇 |
1994年 | 8篇 |
1993年 | 13篇 |
1992年 | 18篇 |
1991年 | 13篇 |
1990年 | 24篇 |
1989年 | 16篇 |
1988年 | 15篇 |
1987年 | 20篇 |
1986年 | 12篇 |
1985年 | 8篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1979年 | 10篇 |
1977年 | 5篇 |
1971年 | 4篇 |
1969年 | 4篇 |
1966年 | 5篇 |
1922年 | 4篇 |
Areas covered: This article covers the pharmacokinetics and pharmacodynamics of vilazodone and provides an evaluation of the clinical usefulness of vilazodone for the treatment of MDD and anxiety disorders. A literature search was performed using PubMed/MEDLINE, Web of Science and the Cochrane Library.
Expert opinion: Studies have shown that vilazodone is significantly superior to placebo. However, vilazodone cannot as yet be recommended as a first-line treatment option for MDD as it is unclear whether the drug’s dual mechanism of action provides greater efficacy than prevailing treatment options. Moreover, more phase IV studies are needed to establish its efficacy and long-term safety in larger and more diverse populations. Although vilazodone may have an additional advantage for the treatment of anxiety symptoms in MDD, here also additional studies are required to confirm its efficacy over and above SSRI alternatives and other antidepressant treatments. Therefore, presently, vilazodone should be considered as a second- or third-line treatment option for MDD and GAD. 相似文献
Objective
To discover the experiences of end-of-life patients attended by the emergency services, through the discourse of the family caregivers who accompanied the family member in this care transit.Method
A qualitative approach study, based on the paradigm of hermeneutical phenomenology. In total, 81 family caregivers participated. The techniques used were the in-depth interview and the discussion group, with a total of 5 discussion groups and 41 interviews. The period of data collection was carried out between January 2013 and June 2014.Results
In the network of discourses obtained with respect to “Urgent Care”, all the codes were grouped in relation to a single argumentative line: deficiencies in urgent care. Among them, we found different dimensions that are established depending on the different times of care, or the different determinant aspects of these deficiencies: disorganization of the care received, lack of experience of the professionals in emergencies, application of general protocols in the emergency services, inadequate care in the treatment received, delays in emergency care.Conclusions
In general, we highlight the dissatisfaction of the family members with respect to the care received from the emergency services. The needs of these types of situation are not covered from these services and are of low quality. Therefore, it is necessary to reorient the care protocols for these patients. 相似文献Methods: Two hundred consecutive diabetic patients undergoing on-pump heart surgery were enrolled. A standard insulin protocol based on subcutaneous intermediary insulin was given the morning of the surgery. Intravenous insulin therapy was initiated intraoperatively from blood glucose concentrations of 180 mg/dl or greater and titrated according to a predefined protocol. Poor intraoperative glycemic control was defined as four consecutive blood glucose concentrations greater than 200 mg/dl without any decrease in despite insulin therapy. Postoperative blood glucose concentrations were maintained below 140 mg/dl by using aggressive insulin therapy. The main endpoints were severe cardiovascular, respiratory, infectious, neurologic, and renal in-hospital morbidity.
Results: Insulin therapy was required intraoperatively in 36% of patients, and poor intraoperative glycemic control was observed in 18% of patients. Poor intraoperative glycemic control was significantly more frequent in patients with severe postoperative morbidity (37% vs. 10%; P < 0.001). The adjusted odds ratio for severe postoperative morbidity among patients with a poor intraoperative glycemic control as compared with patients without was 7.2 (95% confidence interval, 2.7-19.0). 相似文献